Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein-Reference-Cited by-同舟云学术

Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein

Published:2020-01-22 Issue:4 Volume:92 Page:331-337
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Rughani Ankur¹^ORCID,Zhang Dongsheng²³,Vairamani Kanimozhi³⁴^ORCID,Dauber Andrew⁵⁶^ORCID,Hwa Vivian²³^ORCID,Krishnan Sowmya¹^ORCID

Affiliation:

1. Section of Diabetes and Endocrinology Department of Pediatrics University of Oklahoma Health Sciences Center Oklahoma City Oklahoma

2. Division of Endocrinology Cincinnati Center for Growth Disorders Cincinnati Children's Hospital Medical Center Cincinnati Ohio

3. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio

4. Division of Oncology, Cancer and Blood Diseases Institute Cincinnati Children's Hospital Medical Center Cincinnati Ohio

5. Division of Endocrinology Children's National Hospital Washington District of Columbia

6. Department of Pediatrics George Washington School of Medicine and Health Sciences Washington District of Columbia

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14148

Reference19 articles.

1. The Insulin-Like Growth Factors and Growth Disorders of Childhood

2. Growth hormone receptor mutations in children with idiopathic short stature;Sanchez JE;J Clin Endocrinol Metab,1998

3. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients—From discovery to treatment

4. Insulin‐like growth factor‐I treatment of children with Laron syndrome (primary growth hormone insensitivity);Laron Z;Pediatr Endocrinol Rev,2008

5. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal overgrowth in a pre-pubescent child treated with pan-FGFR inhibitor;Heliyon;2024-06

2. A Clinical Trial of High-Dose Growth Hormone in a Patient With a Dominant-Negative Growth Hormone Receptor Mutation;The Journal of Clinical Endocrinology & Metabolism;2024-04-10

3. A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature;Hormone Research in Paediatrics;2023-09-19

4. Reporting a novel growth hormone receptor gene variant in an Iranian consanguineous pedigree with Laron syndrome: a case report;BMC Endocrine Disorders;2023-07-20

5. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature;European Journal of Endocrinology;2023-03-21